Journal article

Chronic Lung and Respiratory Conditions Affecting Lungs and Airways

EK Schneider-Futschik

ACS Pharmacology and Translational Science | AMER CHEMICAL SOC | Published : 2022

DOI: 10.1021/acsptsci.2c00138

University of Melbourne Researchers

Related Projects (1)

Project icon

SYSTEMS PHARMACOLOGY OF CYSTIC FIBROSIS TRANSMEMBRANE REGULATOR CORRECTORS AND POTENTIATORS

Cystic fibrosis is a life limiting disease caused by defective or deficient cystic fibrosis trans-membrane conductance regulator activity. T..

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

ACKNOWLEDGMENTS E.K.S.-F. is supported by the NHMRC (Grant ID: APP1157287) and Cystic Fibrosis Australia.

Keywords

32 Biomedical and Clinical Sciences
3101 Biochemistry and Cell Biology
Chemistry, Medicinal
31 Biological Sciences
3214 Pharmacology and Pharmaceutical Sciences
Pharmacology & Pharmacy
Science & Technology
Life Sciences & Biomedicine
3205 Medical Biochemistry and Metabolomics